MDxHealth SA (NASDAQ: MDXH) reported Q4 EPS of ($0.39), $0.18 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $19.39 million versus the consensus estimate of $18.56 million.

GUIDANCE:

MDxHealth SA sees FY2024 revenue of $79-81 million, versus the consensus of $80.36 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.